D-1293-2020 Class II Terminated
FDA drug recall D-1293-2020 was initiated by American Health Packaging on May 19, 2020 and is designated Class II. Reason for recall: Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life). The recall status is terminated (terminated Aug 3, 2022). Affected quantity: 15,755 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 17, 2020
- Initiation Date
- May 19, 2020
- Termination Date
- Aug 3, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,755 cartons
Product description
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton 62584-693-21; NDC Unit Dose 62584-693-11
Reason for recall
Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).
Distribution pattern
USA Nationwide
Code information
Lots 179605, Exp 06/30/2020; 181105, Exp 08/31/2020; 183019, Exp 01/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1293-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026